Literature DB >> 12801855

Fulminant hepatitis subsequent to reactivation of precore mutant hepatitis B virus in a patient with lymphoma treated with chemotherapy and rituximab.

José-Angel Hernández1, Raúl Diloy, David Salat, Neus del Río, Xavier Martínez, Josep-María Castellví.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12801855

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  7 in total

1.  Traditional Chinese medicine syndromes of chronic hepatitis B with precore mutant.

Authors:  Hong-Zhi Yang; Jian-An Zhao; Min Dai; Yong-Wei Li; Yong-Ze Wang; Wei-Bing Guan; He-Ping Xie
Journal:  World J Gastroenterol       Date:  2005-04-07       Impact factor: 5.742

2.  Hepatitis C Virus-related Mixed Cryoglobulinemia: Pathogenesis, Clinica Manifestations, and New Therapies.

Authors:  Neal J Schamberg; Gerond V Lake-Bakaar
Journal:  Gastroenterol Hepatol (N Y)       Date:  2007-09

3.  Preventing hepatitis B reactivation in immunosuppressed patients: is it time to revisit the guidelines?

Authors:  Jinoos Yazdany; Leonard Calabrese
Journal:  Arthritis Care Res (Hoboken)       Date:  2010-05       Impact factor: 4.794

Review 4.  Reactivation of occult hepatitis B virus infection in patients with rheumatic diseases: pathogenesis, risk assessment and prevention.

Authors:  Masaru Kato; Tatsuya Atsumi
Journal:  Rheumatol Int       Date:  2015-11-16       Impact factor: 2.631

5.  Efficacy of prophylactic lamivudine to prevent hepatitis B virus reactivation in B-cell lymphoma treated with rituximab-containing chemotherapy.

Authors:  Yin-Hua Wang; Lei Fan; Li Wang; Run Zhang; Ji Xu; Cheng Fang; Jian-Yong Li; Wei Xu
Journal:  Support Care Cancer       Date:  2012-11-15       Impact factor: 3.603

6.  Addition of rituximab to chop does not increase the risk of cardiotoxicity in patients with non-Hodgkin's lymphoma.

Authors:  Saadettin Kilickap; Bunyamin Yavuz; Sercan Aksoy; Levent Sahiner; Murat Dincer; Hakan Harputluoglu; Mustafa Erman; Kudret Aytemir; Lale Tokgozoglu; Ibrahim Barista
Journal:  Med Oncol       Date:  2008-04-15       Impact factor: 3.064

7.  Rituximab administration and reactivation of HBV.

Authors:  Yutaka Tsutsumi; Reiki Ogasawara; Yusuke Kamihara; Shinichi Ito; Yoshiya Yamamoto; Junji Tanaka; Masahiro Asaka; Masahiro Imamura
Journal:  Hepat Res Treat       Date:  2010-12-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.